GG

Gousiya Gulabsaheb Desai

Active Director Director DIN 11364368
DIN 11364368 First appointment Oct 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Gousiya Gulabsaheb Desai

Gousiya Gulabsaheb Desai is a Director at Mediinsta Pharmaceutical Private Limited (since 2025).

DIN 11364368
Primary Designation Director
First Appointment 06 Oct 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Oct 20252025Active

Board colleagues of Gousiya Gulabsaheb Desai

NameDINCompanyDesignation
Zeba Kaish Bagwan03600814Mediinsta Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mediinsta Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Gousiya Gulabsaheb Desai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gousiya Gulabsaheb Desai

Gousiya Gulabsaheb Desai currently holds 1 directorship: Mediinsta Pharmaceutical Private Limited (Director, since 06 Oct 2025).

Gousiya Gulabsaheb Desai was first appointed on 06 Oct 2025 as Director at Mediinsta Pharmaceutical Private Limited.

The current boards of Gousiya Gulabsaheb Desai's companies include Zeba Kaish Bagwan (Mediinsta Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available